Jones Elaine V
SEC-identified person · CIK 1296907 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Cytomx Therapeutics, Inc. CTMX | Director | filed 2015–2026 |
| Nextcure, Inc. NXTC | Director | filed 2019–2026 |
| Gritstone bio, Inc. GRTS | Director | filed 2019–2025 |
| Ibere Pharmaceuticals IBERU | Director | filed 2021–2021 |
| Mersana Therapeutics, Inc. [MRSN] | Director | filed 2017–2017 |
| Synlogic, INC. SYBX | Director | filed 2015–2015 |
| Neurogene Inc. NLTX | Director | filed 2014–2014 |
| Flexion Therapeutics Inc FLXN | Director | filed 2014–2014 |
| Targacept INC TRGT | Director | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.